Autologous recovery with protractedly undetectable donor chimerisms can precede stable donor engraftment in a nonmyeloablative cord blood transplant

Int J Hematol. 2003 Jul;78(1):73-5. doi: 10.1007/BF02983244.

Abstract

Low levels of donor chimerism on day 28 after hematopoietic stem cell transplantation are highly predictive of a subsequent rejection of donor cells A recent report on nonmyeloablative transplants has demonstrated that patients who engrafted after transplantation had at least 10% donor cells detectable at this time point. A patient is described who received a nonmyeloablative umbilical cord blood transplant and experienced subsequent full engraftment of donor cells despite the absence of donor chimerism at 4 weeks posttransplantation.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cord Blood Stem Cell Transplantation / methods*
  • Graft Survival*
  • Humans
  • Male
  • Time Factors
  • Transplantation Chimera*
  • Transplantation Conditioning / methods
  • Transplantation, Autologous